IAM
TFFP

Iridian Asset Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Iridian Asset Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,319
Closed -$1.34M – 114
2021
Q2 		$1.52M Sell
6,319
-1,835
-23% -$503K 0.03% 69
2021
Q1 		$2.77M Buy
+8,154
New +$3.32M 0.05% 66

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Iridian Asset Management's TFFP Position: Q3 2021 in Review

Iridian Asset Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2021, closing a stake of 6,319 shares — an estimated $1.34M sold.

Iridian Asset Management first reported a position in TFFP in Q1 2021 and held it in 2 quarters. The position peaked at $2.77M in Q1 2021. 54 funds tracked by Wall St. Rank hold TFFP as of Q3 2021.

  • Iridian Asset Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Iridian Asset Management sold 6,319 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $1.34M.
  • Iridian Asset Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Iridian Asset Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $2.77M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Iridian Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.